Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial – The Lancet

by

  1. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial The Lancet
  2. Common drug reduces long COVID, University of Minnesota study shows Star Tribune
  3. New study from UMN researchers says an existing drug is a promising treatment for long COVID MPR News
  4. Low-Dose Naltrexone Could Treat Long COVID Symptoms Verywell Health
  5. Study: Using a diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing long COVID by 40% Medical Xpress
  6. View Full Coverage on Google News

Read original article here

Leave a Comment